Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04083534 |
| Title | First In Human (FIH) Study of REGN5459 in Patients With Relapsed or Refractory Multiple Myeloma (MM) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Regeneron Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Regeneron Study Site | Indianapolis | Indiana | 46202 | United States | Details | |
| Regeneron Study Site | Ann Arbor | Michigan | 48109 | United States | Details | |
| Regeneron Study Site | Rochester | Minnesota | 55905 | United States | Details | |
| Regeneron Study Site | New York | New York | 10029 | United States | Details | |
| Regeneron Study Site | Dallas | Texas | 75390 | United States | Details | |
| Regeneron Study Site | Houston | Texas | 77030 | United States | Details | |
| Regeneron Study Site | Milwaukee | Wisconsin | 53226 | United States | Details |